Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 6,998 shares, a growth of 172.9% from the May 14th total of 2,564 shares. Based on an average daily volume of 6,228 shares, the short-interest ratio is currently 1.1 days.
Algernon Pharmaceuticals Stock Up 8.0%
OTCMKTS:AGNPF opened at $0.43 on Friday. The company has a 50 day moving average price of $0.23 and a 200 day moving average price of $0.11. Algernon Pharmaceuticals has a fifty-two week low of $0.23 and a fifty-two week high of $0.71.
About Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.
The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).
Featured Articles
- Five stocks we like better than Algernon Pharmaceuticals
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
